Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine Decisions

26 May 2017

Abstract excerpt

AIM: Develop and apply a comprehensive and accurate next-generation sequencing based assay to help clinicians to match oncology patients to therapies. MATERIALS & METHODS: assay was assessed using DNA from well-characterized routine clinical formalin-fixed paraffin-embedded (FFPE) specimens and cell lines. RESULTS: The maximum sensitivity of the assay is 99.5% and its accuracy is virtually 100% for detecting...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 28890729
DOI: 10.2217/pme-2017-0011

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Application of a Cancer Genomic Profiling Assay to Guide Precision Medicine DecisionsPMID 28890729Read ↗

Validation of a next-generation sequencing assay for clinical molecular oncology.Semantic proximity Read ↗

Analytical validation and clinical utilization of K-4CARE<sup>TM</sup>: a comprehensive genomic profiling assay with personalized MRD detectionSemantic proximity Read ↗

Clinical Tumor Sequencing: Opportunities and Challenges for Precision Cancer MedicineSemantic proximity Read ↗

Molecular Testing for Diagnostics, Prognostication, and Treatment Stratification in Cancers.Semantic proximity Read ↗

TruSight Oncology 500: Enabling Comprehensive Genomic Profiling and Biomarker Reporting with Targeted SequencingSemantic proximity Read ↗

Comprehensive genomic profiling for oncological advancements by precision medicine.Semantic proximity Read ↗

Molecular profiling for precision cancer therapiesSemantic proximity Read ↗

Current practices and guidelines for clinical next-generation sequencing oncology testing.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in OncologySemantic proximity Read ↗

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in OncologySemantic proximity Read ↗

Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance.Semantic proximity Read ↗

The Genomic Era of Clinical Oncology: Integrated Genomic Analysis for Precision Cancer CareSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.